BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchegiani G, Andrianello S, Perri G, Secchettin E, Maggino L, Malleo G, Bassi C, Salvia R. Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? HPB 2018;20:411-7. [DOI: 10.1016/j.hpb.2017.10.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Müller PC, Hodson J, Kuemmerli C, Kalisvaart M, Pande R, Roberts KJ. Effect of time to surgery in resectable pancreatic cancer: a systematic review and meta-analysis. Langenbecks Arch Surg 2020;405:293-302. [PMID: 32447457 DOI: 10.1007/s00423-020-01893-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Garcia D, Siegel JB, Mahvi DA, Zhang B, Mahvi DM, Camp ER, Graybill W, Savage SJ, Giordano A, Giordano S, Carneiro-Pla D, Javid M, Lesher AP, Abbott A, DeMore NK. What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer. Clin Oncol Res 2020;3:1-11. [PMID: 34142081 DOI: 10.31487/j.COR.2020.06.05] [Reference Citation Analysis]
3 Marchegiani G, Perri G, Bianchi B, Esposito A, Landoni L, Casetti L, Tuveri M, Malleo G, Paiella S, Fontana M, Pea A, De Pastena M, Salvia R, Bassi C. Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020. Updates Surg 2021. [PMID: 34689316 DOI: 10.1007/s13304-021-01197-y] [Reference Citation Analysis]
4 Casolino R, Braconi C, Malleo G, Paiella S, Bassi C, Milella M, Dreyer SB, Froeling FEM, Chang DK, Biankin AV, Golan T. Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Ann Oncol 2021;32:183-96. [PMID: 33248227 DOI: 10.1016/j.annonc.2020.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
5 Fligor SC, Wang S, Allar BG, Tsikis ST, Ore AS, Whitlock AE, Calvillo-Ortiz R, Arndt KR, Gangadharan SP, Callery MP. Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery. J Gastrointest Surg 2020;24:2357-73. [PMID: 32607860 DOI: 10.1007/s11605-020-04712-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
6 Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer. Cancer Treat Rev 2021;99:102208. [PMID: 34238640 DOI: 10.1016/j.ctrv.2021.102208] [Reference Citation Analysis]
7 Joliat GR, Labgaa I, Gilgien J, Demartines N. Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma. Pancreas 2021;50:104-10. [PMID: 33370031 DOI: 10.1097/MPA.0000000000001719] [Reference Citation Analysis]
8 Steen MW, van Rijssen LB, Festen S, Busch OR, Groot Koerkamp B, van der Geest LG, de Hingh IH, van Santvoort HC, Besselink MG, Gerhards MF; Dutch Pancreatic Cancer Group. Impact of time interval between multidisciplinary team meeting and intended pancreatoduodenectomy on oncological outcomes. BJS Open 2020;4:884-92. [PMID: 32841533 DOI: 10.1002/bjs5.50319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Gavazzi F, Capretti G, Giordano L, Ridolfi C, Spaggiari P, Sollai M, Carrara S, Nappo G, Bozzarelli S, Zerbi A. Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival. Dig Liver Dis 2021:S1590-8658(21)00322-4. [PMID: 34219044 DOI: 10.1016/j.dld.2021.06.006] [Reference Citation Analysis]
10 Lukács G, Kovács Á, Csanádi M, Moizs M, Repa I, Kaló Z, Vokó Z, Pitter JG. Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence. Cancer Manag Res 2019;11:9849-61. [PMID: 31819622 DOI: 10.2147/CMAR.S221427] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Seo HK, Hwang DW, Park SY, Park Y, Lee SJ, Lee JH, Song KB, Lee YJ, Kim SC. The survival impact of surgical waiting time in patients with resectable pancreatic head cancer. Ann Hepatobiliary Pancreat Surg 2018;22:405-11. [PMID: 30588533 DOI: 10.14701/ahbps.2018.22.4.405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Buonaguro FM, Botti G, Ascierto PA, Pignata S, Ionna F, Delrio P, Petrillo A, Cavalcanti E, Di Bonito M, Perdonà S, De Laurentiis M, Fiore F, Palaia R, Izzo F, D'Auria S, Rossi V, Menegozzo S, Piccirillo M, Celentano E, Cuomo A, Normanno N, Tornesello ML, Saviano R, Barberio D, Buonaguro L, Giannoni G, Muto P, Miscio L, Bianchi AAM; and the INT-Pascale COVID-19 Crisis Unit. The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic. Infect Agent Cancer 2020;15:69. [PMID: 33292365 DOI: 10.1186/s13027-020-00330-7] [Reference Citation Analysis]
13 Milella M, Bassi C, Boggi U, Brunetti O, Cavaliere A, Crippa S, De Vita F, Falconi M, Frassineti GL, Giommoni E, Macchini M, Malleo G, Silvestris N, Tudisco A, Vasile E, Reni M. Evolving pancreatic cancer treatment: From diagnosis to healthcare management. Crit Rev Oncol Hematol 2021;169:103571. [PMID: 34923121 DOI: 10.1016/j.critrevonc.2021.103571] [Reference Citation Analysis]
14 Pandé R, Hodson J, Murray A, Marcon F, Kalisvaart M, Marudanayagam R, Sutcliffe RP, Mirza DF, Isaac J, Roberts KJ. Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer. BJS Open 2019;3:476-84. [PMID: 31388640 DOI: 10.1002/bjs5.50161] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Brugel M, Bouché O, Kianmanesh R, Teuma L, Tashkandi A, Regimbeau JM, Pessaux P, Royer B, Rhaiem R, Perrenot C, Neuzillet C, Piardi T, Deguelte S. Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma. BMC Surg 2021;21:413. [PMID: 34876080 DOI: 10.1186/s12893-021-01409-7] [Reference Citation Analysis]
16 Giuliani T, Di Gioia A, Andrianello S, Marchegiani G, Bassi C. Pancreatoduodenectomy associated with colonic resections: indications, pitfalls, and outcomes. Updates Surg 2021;73:379-90. [PMID: 33582983 DOI: 10.1007/s13304-021-00996-7] [Reference Citation Analysis]
17 Kirkegård J, Mortensen FV, Hansen CP, Mortensen MB, Sall M, Fristrup C. Waiting time to surgery and pancreatic cancer survival: A nationwide population-based cohort study. Eur J Surg Oncol 2019;45:1901-5. [PMID: 31160135 DOI: 10.1016/j.ejso.2019.05.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]